Search for: "In re: Asbestos Products v." Results 161 - 180 of 263
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Jun 2013, 5:29 am by Schachtman
Supp. 247 (1984), rev’d on other grounds, 816 F.2d 1417 (10th Cir. 1987) In re TMI Litig., 927 F. [read post]
10 Nov 2011, 8:11 am by Susan I. Nelson
Two, the court lifts a major corporation back on the hook for asbestos claims despite the mighty efforts of the Texas Civil Justice League, the Product Liability Advisory Council, and the Texas Attorney General's office. [read post]
25 Apr 2015, 11:03 am by Schachtman
In both cases, plaintiffs’ expert witnesses committed to opinions about plaintiffs’ being at risk from asbestos exposure, based upon studies that they identified. [read post]
3 Jul 2008, 7:26 pm
Asbestos comes to mind with respect to increased risk claims. [read post]
29 May 2014, 8:45 am by WIMS
Appeals Court Environmental Decisions   <> US v. [read post]
31 Aug 2007, 11:08 am
Therefore, I would reverse the decision of the trial court.In Asbestos Corporation Limited v. [read post]
19 Jul 2022, 6:14 am by admin
App. 2013 (mentioning Kramer as plaintiffs’ expert witness); In re Chan [read post]
18 Apr 2019, 9:05 pm by Alana Bevan
Environmental Protection Agency (EPA) finalized a rule that expands the agency’s authority to prohibit the sale of asbestos-containing products. [read post]
21 Jan 2023, 6:07 pm by admin
Asbestos litigation existed as workman’s compensation cases from the 1930s, and as occasional, isolated cases against manufacturers, from the late 1950s.[1] By 1970, federal regulation of asbestos, in both occupational and environmental settings, however, helped create a legal perpetual motion machine that is still running, half a century later. [read post]
15 Apr 2009, 4:44 am
The Delaware Supreme Court refused to permit an asbestos-related medical monitoring claim in Mergenthaler v. [read post]
4 Nov 2018, 10:56 am by Schachtman
Pl., Feb. 10, 2016) (Bernstein, J.). 2 Institute of Medicine of the National Academies, Asbestos: Selected Health Effects (2006). 3 In re Accutane Litig., ___ N.J. ___, ___ A.3d ___, 2018 WL 3636867 (2018); see “N.J. [read post]